FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2152803022> ?p ?o ?g. }

• W2152803022 endingPage "14" @default.
• W2152803022 startingPage "7" @default.
• W2152803022 abstract "We investigated if inhibition of mitogen-activated protein kinases (MAPKs) was beneficial in Crohn's disease.Inhibition of JNK and p38 MAPK activation with CNI-1493, a guanylhydrazone, was tested in vitro. Twelve patients with severe Crohn's disease (mean baseline, CDAI 380) were randomly assigned to receive either 8 or 25 mg/m(2) CNI-1493 daily for 12 days. Clinical endpoints included safety, Crohn's Disease Activity Index (CDAI), Inflammatory Bowel Disease Questionnaire, and the Crohn's Disease Endoscopic Index of Severity.Colonic biopsies displayed enhanced JNK and p38 MAPK activation. CNI-1493 inhibition of both JNK and p38 phosphorylation was observed in vitro. Treatment resulted in diminished JNK phosphorylation and tumor necrosis factor production as well as significant clinical benefit and rapid endoscopic ulcer healing. No serious adverse events were noted. A CDAI decrease of 120 at week 4 (P = 0.005) and 146.5 at week 8 (P = 0.005) was observed. A clinical response was seen in 67% of patients at 4 weeks and 58% at 8 weeks. Clinical remission was observed in 25% of patients at week 4 and 42% at week 8. Endoscopic improvement occurred in all but 1 patient. Response was seen in 3 of 6 infliximab failures, 2 of whom showed remission. Fistulae healing occurred in 4 of 5 patients, and steroids were tapered in 89% of patients.Inflammatory MAPKs are critically involved in the pathogenesis of Crohn's disease and their inhibition provides a novel therapeutic strategy." @default.
• W2152803022 created "2016-06-24" @default.
• W2152803022 creator A5005552630 @default.
• W2152803022 creator A5007708670 @default.
• W2152803022 creator A5034348684 @default.
• W2152803022 creator A5038082919 @default.
• W2152803022 creator A5058619987 @default.
• W2152803022 creator A5068095052 @default.
• W2152803022 creator A5069908102 @default.
• W2152803022 creator A5078627834 @default.
• W2152803022 creator A5088515652 @default.
• W2152803022 date "2002-01-01" @default.
• W2152803022 modified "2023-10-16" @default.
• W2152803022 title "Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease" @default.
• W2152803022 cites W1501833360 @default.
• W2152803022 cites W1642457845 @default.
• W2152803022 cites W1670573097 @default.
• W2152803022 cites W1671682816 @default.
• W2152803022 cites W1965841992 @default.
• W2152803022 cites W1971685694 @default.
• W2152803022 cites W1971925643 @default.
• W2152803022 cites W1991425488 @default.
• W2152803022 cites W2007452858 @default.
• W2152803022 cites W2055105462 @default.
• W2152803022 cites W2056672563 @default.
• W2152803022 cites W2122057254 @default.
• W2152803022 cites W2145549313 @default.
• W2152803022 cites W2153734123 @default.
• W2152803022 cites W2157433609 @default.
• W2152803022 cites W2171484002 @default.
• W2152803022 cites W2321453230 @default.
• W2152803022 cites W3149527659 @default.
• W2152803022 cites W4300196626 @default.
• W2152803022 cites W81053947 @default.
• W2152803022 doi "https://doi.org/10.1053/gast.2002.30770" @default.
• W2152803022 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11781274" @default.
• W2152803022 hasPublicationYear "2002" @default.
• W2152803022 type Work @default.
• W2152803022 sameAs 2152803022 @default.
• W2152803022 citedByCount "339" @default.
• W2152803022 countsByYear W21528030222012 @default.
• W2152803022 countsByYear W21528030222013 @default.
• W2152803022 countsByYear W21528030222014 @default.
• W2152803022 countsByYear W21528030222015 @default.
• W2152803022 countsByYear W21528030222016 @default.
• W2152803022 countsByYear W21528030222017 @default.
• W2152803022 countsByYear W21528030222018 @default.
• W2152803022 countsByYear W21528030222019 @default.
• W2152803022 countsByYear W21528030222020 @default.
• W2152803022 countsByYear W21528030222021 @default.
• W2152803022 countsByYear W21528030222022 @default.
• W2152803022 countsByYear W21528030222023 @default.
• W2152803022 crossrefType "journal-article" @default.
• W2152803022 hasAuthorship W2152803022A5005552630 @default.
• W2152803022 hasAuthorship W2152803022A5007708670 @default.
• W2152803022 hasAuthorship W2152803022A5034348684 @default.
• W2152803022 hasAuthorship W2152803022A5038082919 @default.
• W2152803022 hasAuthorship W2152803022A5058619987 @default.
• W2152803022 hasAuthorship W2152803022A5068095052 @default.
• W2152803022 hasAuthorship W2152803022A5069908102 @default.
• W2152803022 hasAuthorship W2152803022A5078627834 @default.
• W2152803022 hasAuthorship W2152803022A5088515652 @default.
• W2152803022 hasBestOaLocation W21528030221 @default.
• W2152803022 hasConcept C126322002 @default.
• W2152803022 hasConcept C132149769 @default.
• W2152803022 hasConcept C17991360 @default.
• W2152803022 hasConcept C184235292 @default.
• W2152803022 hasConcept C197934379 @default.
• W2152803022 hasConcept C2777138892 @default.
• W2152803022 hasConcept C2778260677 @default.
• W2152803022 hasConcept C2779134260 @default.
• W2152803022 hasConcept C2779280984 @default.
• W2152803022 hasConcept C2780942790 @default.
• W2152803022 hasConcept C51551487 @default.
• W2152803022 hasConcept C57074206 @default.
• W2152803022 hasConcept C71924100 @default.
• W2152803022 hasConcept C86803240 @default.
• W2152803022 hasConcept C90924648 @default.
• W2152803022 hasConcept C95444343 @default.
• W2152803022 hasConceptScore W2152803022C126322002 @default.
• W2152803022 hasConceptScore W2152803022C132149769 @default.
• W2152803022 hasConceptScore W2152803022C17991360 @default.
• W2152803022 hasConceptScore W2152803022C184235292 @default.
• W2152803022 hasConceptScore W2152803022C197934379 @default.
• W2152803022 hasConceptScore W2152803022C2777138892 @default.
• W2152803022 hasConceptScore W2152803022C2778260677 @default.
• W2152803022 hasConceptScore W2152803022C2779134260 @default.
• W2152803022 hasConceptScore W2152803022C2779280984 @default.
• W2152803022 hasConceptScore W2152803022C2780942790 @default.
• W2152803022 hasConceptScore W2152803022C51551487 @default.
• W2152803022 hasConceptScore W2152803022C57074206 @default.
• W2152803022 hasConceptScore W2152803022C71924100 @default.
• W2152803022 hasConceptScore W2152803022C86803240 @default.
• W2152803022 hasConceptScore W2152803022C90924648 @default.
• W2152803022 hasConceptScore W2152803022C95444343 @default.
• W2152803022 hasIssue "1" @default.
• W2152803022 hasLocation W21528030221 @default.
• W2152803022 hasLocation W21528030222 @default.

• next